Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Brandes Small Cap Value Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initiating new positions in resilient, discounted small-caps."
In Q4 2025, the Brandes Small Cap Value Fund returned 5.88% (Class I), outperforming both the Russell 2000 Index (2.19%) and the Russell 2000 Value Index (3.26%). Over the YTD period, the Fund rose 23.42% compared to 12.81% for the Russell 2000. Outperformance was driven by stock selection across multiple sectors, primarily led by Industrials holdings such as Kennametal and Graham Corporation. The Fund completed the full divestment of Avadel Pharmaceuticals during the quarter following a bidding war that pushed the stock price to its intrinsic value. Concurrently, the Fund initiated a position in Central Garden & Pet Company (CENT), capitalizing on share price weakness driven by post-pandemic normalization.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
Growth Outlook
Market outlook remains above average conviction: The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
Risk Appetite
Risk appetite posture is above average conviction: The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
Forward Guidance
Forward guidance signal: The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
Language Signal
Tone analysis indicates above average conviction language: The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Brandes Small Cap Value Fund delivered strong absolute and relative performance in Q4 2025, outperforming its benchmark by capturing value through stock-specific M&A and initia...
